Argentina Enteral Feeding Formulas Market Size, Share & Trends Analysis Report By Product (Disease-specific Formulas, Standard Formula), By Flow Type, By Stage (Adult, Pediatric), By Indication, By End-use, By Sales Channel, And Segment Forecasts, 2025 -

Argentina Enteral Feeding Formulas Market Growth & Trends

The Argentina enteral feeding formulas market size is expected to reach USD 89.5 million by 2030, registering a CAGR of 5.99% from 2025 to 2030, according to a new report by Grand View Research, Inc. This growth is attributed to the country's aging population, which has led to a higher prevalence of chronic diseases such as diabetes, cancer, and gastrointestinal disorders, thereby increasing the demand for enteral nutrition solutions. In addition, advancements in healthcare infrastructure and increased awareness about the benefits of enteral nutrition have further propelled market growth. The development of disease-specific formulas and the introduction of innovative products tailored to individual patient needs have also played a crucial role in driving the market forward.

Argentina has implemented several clinical nutrition initiatives to address malnutrition and promote public health, significantly driving market growth in this sector. In November 2021, the country enacted the Health Food Promotion Law, introducing comprehensive, evidence-based food policies. These include front-of-package warning labels, advertising restrictions, and regulations within school environments to combat diet-related non-communicable diseases. In addition, organizations like Haciendo Camino have developed programs to provide nutritional treatment and support to families in their homes. These initiatives aim to improve child nutrition and overall family health.

Moreover, the Franciscan Missions have established health and nutrition programs focusing on overcoming malnutrition among children aged 0 to 5 years and pregnant women, particularly in remote rural areas lacking adequate healthcare facilities. This program directly benefits over 700 children and more than 500 mothers, with an indirect positive impact on approximately 2,300 individuals. These initiatives, among others, have contributed to the advancement of clinical nutrition in Argentina, fostering market growth and improving public health outcomes.

The COVID-19 pandemic has positively impacted market growth as the rate of hospitalization increased considerably, which impelled the demand for enteral feeding formulas for critically ill patients. These patients had reduced oral intake due to nausea, anorexia, and impairment of taste, which increased the need for enteral feeding formulas to provide nourishment. The key players tried to manage their products to meet the growing demand for enteral formulas for critically ill patients. For instance, according to an article published in Elsevier Public Health Emergency Collection, around half of critically ill COVID-19 patients develop gastrointestinal problems such as gastrointestinal hypomotility. In addition, patients experience various other abdominal problems, leading to an increase in the adoption of enteral feeding tubes.

Argentina Enteral Feeding Formulas Market Report Highlights

• Based on product, the disease-specific formulas segment dominated the market and held the largest market share of 50.54% in 2024 owing to an increase in the prevalence of several chronic disorders, such as diabetes, cancer, and cardiovascular disease require personalized products.
• Based on flow type, the intermittent tube feeding segment dominated the market with the largest revenue share in 2024. In the elderly population, malnutrition and dysphagia are common and can lead to nutritional deficiency, thereby increasing the need for enteral feeding to provide essential nutrients.
• Based on stage, the adult segment dominated the market in 2024 owing to the rising prevalence of malnutrition and undernourishment in Argentina.
• Based on indication, the cancer care segment held the largest market share in 2024, driven by the increasing premature cancer-related fatalities annually, resulting in an average life expectancy that is 1.8 years shorter than it would be in the absence of cancer.
• Based on end use, the home care segment held the largest market share in 2024, driven by the rising preference for home healthcare, which offers patients a more comfortable environment and reduces the burden on healthcare facilities.
• Major players are employing various strategies such as product launches, collaborations, acquisitions, and mergers to expand their service portfolios and enhance their geographical presence, leading to significant competition within the market. For instance, in May 2022, Nestlé Health Science acquired Puravida, a premium Brazilian health and nutrition lifestyle brand. This acquisition aims to expand Nestlé’s customer base in Brazil.